Sagent Pharmaceuticals Stock Price, News & Analysis
SGNT
Company Description
Sagent Pharmaceuticals (Nasdaq: SGNT) is a publicly traded company.
SGNT stock has gained 8.9% over the past year.
This page provides a comprehensive overview of SGNT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$—
0.00%
0.00
Last updated:
+8.91%
Performance 1 year
$0.0
Sagent Pharmaceuticals (SGNT) stock. Over the past 12 months, the stock has gained 8.9%.
Latest News
Sagent Pharmaceuticals has 2 recent news articles. Key topics include management, AI. View all SGNT news →
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months